|
122 Companies |
|
196 Products |
|
196 Products |
|
116 Mechanisms of Action |
|
3 Trials |
|
2338 News |
|
| «12...3132333435363738394041...4647» |
- | tetrabenazine / Generic mfg.
Trial completion: Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease (clinicaltrials.gov) - May 6, 2013
P4, N=15, Completed, Sponsor: Ohio State University
Recruiting --> Completed
- | New P2 trial: TMS-AD: Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease (clinicaltrials.gov) - May 5, 2013
P2, N=56, Recruiting, Sponsor: Centre for Addiction and Mental Health
- ||||| New P2 trial: Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis (clinicaltrials.gov) - May 5, 2013
P2, N=158, Recruiting, Sponsor: University of Miami
- | New P2 trial: NEURITES: NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects (clinicaltrials.gov) - May 5, 2013
P2, N=100, Recruiting, Sponsor: National University Hospital, Singapore
- | donepezil / Generic mfg.
New P4 trial: Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil (clinicaltrials.gov) - May 1, 2013
P4, N=60, Recruiting, Sponsor: New York State Psychiatric Institute
- Clinical: CONCEPT: Predictive Value of the Distress Thermometer as a Predictive Screening Instrument to Detect Cancer-related Cognitive Impairment in Cancer Patients (clinicaltrials.gov) - May 1, 2013
P=N/A, N=125, Recruiting, Sponsor: General Hospital Groeninge
- Enrollment change: Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease (clinicaltrials.gov) - Apr 30, 2013
P2, N=12, Completed, Sponsor: The New York Memory Services
Recruiting --> Completed N=10 --> 12
- Trial completion: Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease (clinicaltrials.gov) - Apr 30, 2013
P2, N=12, Completed, Sponsor: The New York Memory Services
N=10 --> 12 Recruiting --> Completed
- atomoxetine / Generic mfg.
Trial termination: The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype (clinicaltrials.gov) - Apr 29, 2013
P2, N=11, Terminated, Sponsor: National Institute of Mental Health (NIMH)
Recruiting --> Completed Completed --> Terminated; The scientific director decided to terminate: low priority study with slow accrual
- Enrollment open: Retinal Neurodegenerative Signs in Alzheimer's Diseases (clinicaltrials.gov) - Apr 29, 2013
P=N/A, N=450, Recruiting, Sponsor: University Hospital, Bordeaux
Completed --> Terminated; The scientific director decided to terminate: low priority study with slow accrual Not yet recruiting --> Recruiting
- ||| Trial completion: NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support) (clinicaltrials.gov) - Apr 28, 2013
P=N/A, N=204, Completed, Sponsor: Pamlab, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- New P1 trial: Meaningful Activity Intervention for Persons With Mild Cognitive Impairment (clinicaltrials.gov) - Apr 28, 2013
P1, N=72, Recruiting, Sponsor: Indiana University
- ||||| galantamine hydrobromide / Generic mfg.
Trial initiation date: An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease (clinicaltrials.gov) - Apr 24, 2013
P3, N=580, Completed, Sponsor: Janssen Pharmaceutical K.K.
Active, not recruiting --> Completed Initiation date: Jan 2006 --> Feb 2007
- | escitalopram / Generic mfg.
New P4 trial: Escitalopram for the Treatment of Depression in Alzheimer's Disease (clinicaltrials.gov) - Apr 24, 2013
P4, N=84, Active, not recruiting, Sponsor: Konkuk University Medical Center
- Humalog pen (insulin lispro) / Eli Lilly
Trial initiation date: Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease (clinicaltrials.gov) - Apr 22, 2013
P=N/A, N=0, Withdrawn, Sponsor: Louisiana State University Health Sciences Center Shreveport
Initiation date: Jan 2006 --> Feb 2007 Initiation date: Sep 2012 --> Sep 2013
- ||| Trial completion: Clinical Pathway for Alzheimer's Disease in China (CPAD) (clinicaltrials.gov) - Apr 22, 2013
P=N/A, N=1024, Completed, Sponsor: Peking University
Initiation date: Sep 2012 --> Sep 2013 Active, not recruiting --> Completed
- ||| donanemab (LY3002813) / Eli Lilly
New P1 trial: A Study of LY3002813 in Participants With Alzheimer's Disease (clinicaltrials.gov) - Apr 21, 2013
P1, N=100, Recruiting, Sponsor: Eli Lilly and Company
- LMTX (hydromethylthionine) / TauRx
Trial termination: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 17, 2013
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
Active, not recruiting --> Completed Recruiting --> Terminated; This study has been terminated for administrative reasons only.
- LMTX (hydromethylthionine) / TauRx
Enrollment change: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 17, 2013
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
Recruiting --> Terminated; This study has been terminated for administrative reasons only. N=60 --> 9
- Victoza (liraglutide) / Novo Nordisk
Trial completion: Identifying Potential Effects of Liraglutide on Degenerative Changes (clinicaltrials.gov) - Apr 17, 2013
P=N/A, N=34, Completed, Sponsor: University of Aarhus
N=60 --> 9 Recruiting --> Completed
- | minocycline / Generic mfg.
Trial initiation date: Pilot Study of Minocycline in Huntington's Disease (clinicaltrials.gov) - Apr 16, 2013
P2/3, N=114, Completed, Sponsor: Merit Cudkowicz
Recruiting --> Completed Initiation date: Jan 2006 --> Apr 2006
- | minocycline / Generic mfg.
Trial completion: Pilot Study of Minocycline in Huntington's Disease (clinicaltrials.gov) - Apr 16, 2013
P2/3, N=114, Completed, Sponsor: Merit Cudkowicz
Initiation date: Jan 2006 --> Apr 2006 Active, not recruiting --> Completed
- Trial initiation date, HEOR: MBCT_AD: Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=60, Not yet recruiting, Sponsor: Lakehead University
Active, not recruiting --> Completed Initiation date: Feb 2013 --> Aug 2013
- tetrabenazine / Generic mfg.
New P4 trial: Effect of Tetrabenazine on Stroop Interference in HD (clinicaltrials.gov) - Apr 14, 2013
P4, N=10, Recruiting, Sponsor: New York Medical College
- tetrabenazine / Generic mfg.
Enrollment open: Effect of Tetrabenazine on Stroop Interference in HD (clinicaltrials.gov) - Apr 14, 2013
P4, N=10, Recruiting, Sponsor: New York Medical College
Initiation date: Feb 2013 --> Aug 2013 Not yet recruiting --> Recruiting
- Enrollment open: Brain Alterations and Cognitive Impairment in Older Adults With Heart Failure (clinicaltrials.gov) - Apr 11, 2013
P=N/A, N=47, Recruiting, Sponsor: University of Wisconsin, Madison
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment change: STERMEM: Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=90, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting --> Recruiting N=200 --> 90
- Trial completion: STERMEM: Pregnenolone Sulfate an Early Marker of the Memory Loss in Alzheimer's Disease (clinicaltrials.gov) - Apr 9, 2013
P=N/A, N=90, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
N=200 --> 90 Recruiting --> Completed
- New P1 trial: PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers (clinicaltrials.gov) - Apr 4, 2013
P1, N=30, Recruiting, Sponsor: Dean F. Wong, MD, PhD
- Daytrana (methylphenidate transdermal system) / Hisamitsu
New P4 trial: Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia. (clinicaltrials.gov) - Apr 3, 2013
P4, N=40, Enrolling by invitation, Sponsor: St. Louis University
- ||||| Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
New P4 trial: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) (clinicaltrials.gov) - Apr 2, 2013
P4, N=510, Not yet recruiting, Sponsor: Ever Neuro Pharma GmbH
- midodrine hydrochloride / Generic mfg.
New P4 trial: Body Temperature in Persons With Tetraplegia When Exposed to Cold (clinicaltrials.gov) - Mar 31, 2013
P4, N=30, Recruiting, Sponsor: James J. Peters Veterans Affairs Medical Center
- Clinical data, Trial completion: ZZH-2: Subclinical Delirium and Clinical Outcome (clinicaltrials.gov) - Mar 31, 2013
P=N/A, N=250, Completed, Sponsor: Jinhua Central Hospital
Recruiting --> Completed Recruiting --> Completed
- methylphenidate tablet / Generic mfg.
Trial completion: Apathy in Dementia Methylphenidate Trial (ADMET) (clinicaltrials.gov) - Mar 31, 2013
P2, N=60, Completed, Sponsor: Johns Hopkins Bloomberg School of Public Health
Recruiting --> Completed Active, not recruiting --> Completed
- | donepezil / Generic mfg.
Trial initiation date: MUSTARDD-PD: Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease (clinicaltrials.gov) - Mar 26, 2013
P3, N=500, Recruiting, Sponsor: Sharon Erb
Active, not recruiting --> Completed Initiation date: May 2012 --> Jan 2013
- | Enrollment change: A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium (clinicaltrials.gov) - Mar 26, 2013
P3, N=325, Completed, Sponsor: University of Colorado, Denver
Initiation date: May 2012 --> Jan 2013 N=163 --> 325
- | donepezil / Generic mfg.
Enrollment open: MUSTARDD-PD: Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease (clinicaltrials.gov) - Mar 26, 2013
P3, N=500, Recruiting, Sponsor: Sharon Erb
N=163 --> 325 Not yet recruiting --> Recruiting
- | Trial completion: A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium (clinicaltrials.gov) - Mar 26, 2013
P3, N=325, Completed, Sponsor: University of Colorado, Denver
Not yet recruiting --> Recruiting Recruiting --> Completed
- |||||| LMTX (hydromethylthionine) / TauRx
Enrollment open: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Mar 26, 2013
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: TMS Stimulation and Cognitive Training in Alzheimer Patients (clinicaltrials.gov) - Mar 25, 2013
P1, N=15, Completed, Sponsor: Neuronix Ltd
Not yet recruiting --> Recruiting N=12 --> 15
- | Trial completion: TMS Stimulation and Cognitive Training in Alzheimer Patients (clinicaltrials.gov) - Mar 25, 2013
P1, N=15, Completed, Sponsor: Neuronix Ltd
N=12 --> 15 Recruiting --> Completed
- Trial completion: Creatine Safety and Tolerability in Premanifest HD: PRECREST (clinicaltrials.gov) - Mar 19, 2013
P2, N=64, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD (clinicaltrials.gov) - Mar 19, 2013
P=N/A, N=30, Recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- selisistat (SEN-196) / AOP Orphan Pharma
Enrollment change: A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease (clinicaltrials.gov) - Mar 18, 2013
P1, N=26, Completed, Sponsor: Siena Biotech S.p.A.
Not yet recruiting --> Recruiting N=34 --> 26
- | selisistat (SEN-196) / AOP Orphan Pharma
Trial completion: A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease (clinicaltrials.gov) - Mar 18, 2013
P1, N=26, Completed, Sponsor: Siena Biotech S.p.A.
N=34 --> 26 Active, not recruiting --> Completed
- Enrollment open, HEOR: Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis (clinicaltrials.gov) - Mar 17, 2013
P4, N=40, Recruiting, Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy (clinicaltrials.gov) - Mar 17, 2013
P=N/A, N=331, Completed, Sponsor: Emory University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- haloperidol / Generic mfg., quetiapine / Generic mfg.
New P3 trial: Haloquet: Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium (clinicaltrials.gov) - Mar 12, 2013
P3, N=45, Recruiting, Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
- |||| vanutide cridificar (PF-236806) / J&J, Perrigo Company, Pfizer
Trial completion: Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease (clinicaltrials.gov) - Mar 11, 2013
P2a, N=245, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Ginkgo Biloba Prevention Trial in Older Individuals (clinicaltrials.gov) - Mar 10, 2013
P3, N=3069, Completed, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Active, not recruiting --> Completed Active, not recruiting --> Completed